Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
923 | 2 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE | 11303 |
4792 | 1 | PROSTANOID RECEPTORS//EP RECEPTORS//EP2 RECEPTOR | 1752 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PROSTANOID RECEPTORS | authKW | 559593 | 4% | 47% | 66 |
2 | EP RECEPTORS | authKW | 388831 | 3% | 37% | 59 |
3 | EP2 RECEPTOR | authKW | 373437 | 2% | 59% | 35 |
4 | EP3 RECEPTOR | authKW | 362718 | 2% | 61% | 33 |
5 | EP4 RECEPTOR | authKW | 348632 | 2% | 46% | 42 |
6 | IP RECEPTOR | authKW | 305419 | 2% | 57% | 30 |
7 | EP4 | authKW | 295044 | 2% | 46% | 36 |
8 | EP2 | authKW | 268295 | 2% | 45% | 33 |
9 | PROSTAGLANDIN RECEPTORS | authKW | 264359 | 2% | 35% | 42 |
10 | EP1 ANTAGONIST | authKW | 242350 | 1% | 84% | 16 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2418 | 23% | 0% | 408 |
2 | Biochemistry & Molecular Biology | 1477 | 27% | 0% | 472 |
3 | Cell Biology | 1424 | 16% | 0% | 283 |
4 | Chemistry, Medicinal | 1088 | 8% | 0% | 141 |
5 | Immunology | 814 | 12% | 0% | 208 |
6 | Physiology | 281 | 5% | 0% | 93 |
7 | Biophysics | 269 | 6% | 0% | 97 |
8 | Medicine, Research & Experimental | 248 | 6% | 0% | 99 |
9 | Peripheral Vascular Diseases | 216 | 4% | 0% | 70 |
10 | Chemistry, Organic | 215 | 7% | 0% | 116 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MINASE | 185740 | 3% | 21% | 50 |
2 | PHARMACEUT SCI PHYSIOL CHEM SAKYO KU | 57558 | 0% | 80% | 4 |
3 | MRC UCT GRP RECEPTOR BIOL | 40470 | 0% | 75% | 3 |
4 | INVITRO PHARMACOL | 35975 | 0% | 100% | 2 |
5 | PHARMACOL ANGIOGENESIS | 35975 | 0% | 100% | 2 |
6 | HEADQUARTERS | 34722 | 1% | 10% | 20 |
7 | UMR S698 | 34585 | 0% | 38% | 5 |
8 | P PHARMACOL PHARMACOL TOXICOL SECT | 31973 | 0% | 44% | 4 |
9 | DISCOVERY 1 | 29972 | 0% | 33% | 5 |
10 | HERBERT | 23982 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 32858 | 3% | 3% | 59 |
2 | BRITISH JOURNAL OF PHARMACOLOGY | 10144 | 6% | 1% | 101 |
3 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 4753 | 2% | 1% | 29 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4468 | 5% | 0% | 81 |
5 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 3247 | 1% | 2% | 12 |
6 | PROSTAGLANDINS | 2520 | 1% | 1% | 14 |
7 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 1645 | 1% | 0% | 25 |
8 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1637 | 3% | 0% | 52 |
9 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 1614 | 0% | 2% | 5 |
10 | MOLECULAR PHARMACOLOGY | 1388 | 2% | 0% | 28 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROSTANOID RECEPTORS | 559593 | 4% | 47% | 66 | Search PROSTANOID+RECEPTORS | Search PROSTANOID+RECEPTORS |
2 | EP RECEPTORS | 388831 | 3% | 37% | 59 | Search EP+RECEPTORS | Search EP+RECEPTORS |
3 | EP2 RECEPTOR | 373437 | 2% | 59% | 35 | Search EP2+RECEPTOR | Search EP2+RECEPTOR |
4 | EP3 RECEPTOR | 362718 | 2% | 61% | 33 | Search EP3+RECEPTOR | Search EP3+RECEPTOR |
5 | EP4 RECEPTOR | 348632 | 2% | 46% | 42 | Search EP4+RECEPTOR | Search EP4+RECEPTOR |
6 | IP RECEPTOR | 305419 | 2% | 57% | 30 | Search IP+RECEPTOR | Search IP+RECEPTOR |
7 | EP4 | 295044 | 2% | 46% | 36 | Search EP4 | Search EP4 |
8 | EP2 | 268295 | 2% | 45% | 33 | Search EP2 | Search EP2 |
9 | PROSTAGLANDIN RECEPTORS | 264359 | 2% | 35% | 42 | Search PROSTAGLANDIN+RECEPTORS | Search PROSTAGLANDIN+RECEPTORS |
10 | EP1 ANTAGONIST | 242350 | 1% | 84% | 16 | Search EP1+ANTAGONIST | Search EP1+ANTAGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |